Jeanne Cunicelli, MBA, is a Managing Director of Bay City Capital and has been with the firm since 1997. Her investment activities focus on medical device, drug delivery, and drug development companies.
Ms. Cunicelli joined Bay City Capital from Ernst & Young’s International Life Sciences Group where she managed its industry-leading annual biotechnology report. She is a member of the board of trustees of Carnegie Mellon University and serves on the finance committee and the research and technology commercialization committee. Ms. Cunicelli received an MBA in Finance from the University of San Francisco and holds a BS in Cognitive Psychology from Carnegie Mellon University.